Ontruzant 150 MG vials
Ended Awarded
- Contract number
- SPE2DX25F6UWK
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $1,313
Award facts
- Contract value 100% obligated
- $1,312.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The U.S. Department of Defense's Medical Supply Chain awarded a $1,312.50 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Ontruzant 150 mg vials, with final delivery required by September 15, 2025. This non-set-aside contract was competitively awarded to AmerisourceBergen's Corporate Office, headquartered in Conshohocken, Pennsylvania, where the pharmaceutical products will be sourced and delivered. The delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) vehicle with the Defense Logistics Agency Troop Support Medical, designated SPE2DX and valued at $999,999,999, extending through December 2026.
AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal military and veteran healthcare systems, with demonstrated capability to supply a comprehensive range of medications and medical supplies through competitive procurement processes. The company's federal contract portfolio reflects its role as a primary vendor for Defense Health Agency pharmaceutical needs, providing everything from specialty medications and brand-name drugs to generic pharmaceuticals and medical devices across multiple therapeutic domains. This particular delivery order for Ontruzant, a trastuzumab biosimilar used in oncology treatment, exemplifies the company's specialized medical product delivery capabilities within the broader federal medical supply chain infrastructure.
Quick answers
Who was awarded contract SPE2DX25F6UWK?
SPE2DX25F6UWK was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on September 12, 2025.
How much is contract SPE2DX25F6UWK worth?
The government has obligated $1,313 on SPE2DX25F6UWK.
Is contract SPE2DX25F6UWK an order under another contract?
Yes. SPE2DX25F6UWK is a delivery order under SPE2DX15D1053, an indefinite delivery contract.
Was contract SPE2DX25F6UWK competed?
The extent of competition for SPE2DX25F6UWK was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award